Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Friday . The company traded as low as $3.60 and last traded at $3.64, with a volume of 66404 shares traded. The stock had previously closed at $3.73.
Hypera Trading Down 2.3 %
The stock’s 50-day simple moving average is $4.75 and its 200-day simple moving average is $5.19.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- High Flyers: 3 Natural Gas Stocks for March 2022
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What Are Some of the Best Large-Cap Stocks to Buy?
- MarketBeat Week in Review – 11/4 – 11/8
- What Are Dividends? Buy the Best Dividend Stocks
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
